OS Therapies (NYSE:OSTX) Given “Buy” Rating at D. Boral Capital
D. Boral Capital reissued their buy rating on shares of OS Therapies (NYSE:OSTX – Free Report) in a research note issued to investors on Monday,Benzinga reports. The firm currently has a $20.00 price objective on the stock. Other equities analysts have also issued research reports about the stock. Lake Street Capital assumed coverage on shares […]
D. Boral Capital reissued their buy rating on shares of OS Therapies (NYSE:OSTX – Free Report) in a research note issued to investors on Monday,Benzinga reports. The firm currently has a $20.00 price objective on the stock. Other equities analysts have also issued research reports about the stock. Lake Street Capital assumed coverage on shares […]
